SM
Sabby Management Portfolio holdings
AUM
$13M
This Quarter Return
+3.37%
1 Year Return
-26.95%
3 Year Return
-56.43%
5 Year Return
-61.92%
10 Year Return
-71.17%
AUM
$277M
AUM Growth
+$277M
(-4.1%)
Cap. Flow
-$58.1M
Cap. Flow
% of AUM
-20.99%
Top 10 Holdings %
Top 10 Hldgs %
46.92%
Holding
254
New
38
Increased
26
Reduced
76
Closed
42
Top Buys
| 1 |
Bristol-Myers Squibb
BMY
|
$8.46M |
| 2 |
CELG
Celgene Corp
CELG
|
$3.94M |
| 3 |
United Therapeutics
UTHR
|
$3.32M |
| 4 |
TSRO
TESARO, Inc.
TSRO
|
$2.76M |
| 5 |
Tenet Healthcare
THC
|
$2.56M |
Top Sells
| 1 |
Sarepta Therapeutics
SRPT
|
$15.2M |
| 2 |
VXZ
iPath S&P 500 VIX Mid-Term Futures ETN due 1/30/2019
VXZ
|
$6.65M |
| 3 |
Abbott
ABT
|
$6.42M |
| 4 |
GBT
Global Blood Therapeutics, Inc.
GBT
|
$4.21M |
| 5 |
SCON
Superconductor Technologies Inc.
SCON
|
$3.87M |
Sector Composition
| 1 | Healthcare | 87.44% |
| 2 | Consumer Staples | 0.39% |
| 3 | Technology | 0.24% |
| 4 | Industrials | 0.1% |
| 5 | Materials | 0.02% |
